Other products from "VELA OPERATIONS SINGAPORE PTE. LTD."
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 08885013958157 300353 300353 The Sentosa SX Virus Total Nucleic Acid Kit v2.0 (4x24) is used for magnetic bea The Sentosa SX Virus Total Nucleic Acid Kit v2.0 (4x24) is used for magnetic beads-based nucleic acid extraction from virus in biological specimens. The kit is intended for in vitro diagnostic use. JJH Clinical Sample Concentrator 1 Sentosa SX Virus Total Nucleic Acid Kit v2.0 (4x24)
2 08885013956566 300729 300729 The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-base The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) test intended for use in detecting HIV-1 genomicmutations (in the protease, reverse transcriptase and integrase regions of the pol gene), as an aid in monitoring and treating HIV-1 infection. This test is used in adjunct to the therapeutic management of patients diagnosed with HIV-1 Group M infection, with viral loads of at least 1,000 RNA copies per mL in EDTA plasma specimens.The Sentosa SQ HIV-1 Genotyping Assay consists of Sentosa SQ HIV-1 Genotyping Reagents and Sentosa SQ Virus Testing Solutions. They are used with the Sentosa SQ HIV-1 Positive Control Kit (96/8). QIC Hiv-1 Genotyping Assay Using Ngs Technology 2 Sentosa SQ HIV-1 Positive Control Kit (96)
3 08885013953855 301085 ViroKey® SARS-CoV-2 RT-PCR Test v2.0 (4x96) is a real-time RT-PCR test intended ViroKey® SARS-CoV-2 RT-PCR Test v2.0 (4x96) is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal or nasopharyngeal aspirates, nasal washes and bronchoalveolar lavage samples collected from individuals suspected of COVID-19 by their healthcare provider.Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA. Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. ViroKey® SARS-CoV-2 RT-PCR Test v2.0 (4x96)
4 08885013950007 400089 400089 Sentosa SX101 is an automated pipetting instrument designed for contamination-fr Sentosa SX101 is an automated pipetting instrument designed for contamination-free, precise and correct measuring and transferring of liquids. JQW Station, Pipetting And Diluting, For Clinical Use 1 Sentosa SX101
5 08885013956313 300328 300328 The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion S The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonal amplified DNA for up to 200 base-read sequencing of a library.Sentosa ST Template Kit is comprised of four components; Sentosa ST Template Supplies, Sentosa ST Template Solutions, Sentosa ST Template Reagents and Sentosa ST Template Beads. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa ST Template Supplies (8)
6 08885013956559 300732 300732 The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-base The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) test intended for use in detecting HIV-1 genomicmutations (in the protease, reverse transcriptase and integrase regions of the pol gene), as an aid in monitoring and treating HIV-1 infection. This test is used in adjunct to the therapeutic management of patients diagnosed with HIV-1 Group M infection, with viral loads of at least 1,000 RNA copies per mL in EDTA plasma specimens.The Sentosa SQ HIV-1 Genotyping Assay consists of Sentosa SQ HIV-1 Genotyping Reagents and Sentosa SQ Virus Testing Solutions. They are used with the Sentosa SQ HIV-1 Positive Control Kit (96/8). QIC Hiv-1 Genotyping Assay Using Ngs Technology 2 Sentosa SQ Virus Testing Solutions (4x24)
7 08885013956375 300313 300313 The Sentosa SQ Sequencing Kit is used to perform up to 200 base-read sequencing The Sentosa SQ Sequencing Kit is used to perform up to 200 base-read sequencing of enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonally amplified DNA. The Sentosa SQ Sequencing Kit is comprised of three components; Sentosa SQ Sequencing Supplies, Sentosa SQ Sequencing Solutions and Sentosa SQ Sequencing Reagents. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa SQ Sequencing Reagents (8)
8 08885013956320 300319 300319 The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion S The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonal amplified DNA for up to 200 base-read sequencing of a library.Sentosa ST Template Kit is comprised of four components; Sentosa ST Template Supplies, Sentosa ST Template Solutions, Sentosa ST Template Reagents and Sentosa ST Template Beads. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa ST Template Reagents (8)
9 08885013953817 301068 ViroKey® SARS-CoV-2 RT-PCR Test v2.0 (8x48) is a real-time RT-PCR test intended ViroKey® SARS-CoV-2 RT-PCR Test v2.0 (8x48) is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal or nasopharyngeal aspirates, nasal washes and bronchoalveolar lavage samples collected from individuals suspected of COVID-19 by their healthcare provider.Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA. Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. ViroKey® SARS-CoV-2 RT-PCR Test v2.0 (8x48)
10 08885013950021 400125 400125 The Sentosa SA201 Real-Time PCR Instrument is a real-time nucleic acid amplifica The Sentosa SA201 Real-Time PCR Instrument is a real-time nucleic acid amplification and detection system. It measures nucleic acid signals from reverse transcribed RNA and converts the signals to comparative quantitative readouts using fluorescent detection of dual-labeled hydrolysis probes. OOI Real Time Nucleic Acid Amplification System 2 Sentosa SA201 Real-Time PCR Instrument
11 08885013958171 300395 300395 The Sentosa SX Virus Total Nucleic Acid Plus Kit (4x24) is used for magnetic bea The Sentosa SX Virus Total Nucleic Acid Plus Kit (4x24) is used for magnetic beads-based nucleic acid extraction from virus in biological specimens. The kit is intended for in vitro diagnostic use. JJH Clinical Sample Concentrator 1 Sentosa SX Virus Total Nucleic Acid Plus Kit (4x24)
12 08885013956597 300800 300800 The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-base The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) test intended for use in detecting HIV-1 genomicmutations (in the protease, reverse transcriptase and integrase regions of the pol gene), as an aid in monitoring and treating HIV-1 infection. This test is used in adjunct to the therapeutic management of patients diagnosed with HIV-1 Group M infection, with viral loads of at least 1,000 RNA copies per mL in EDTA plasma specimens.The Sentosa SQ HIV-1 Genotyping Assay consists of Sentosa SQ HIV-1 Genotyping Reagents and Sentosa SQ Virus Testing Solutions. They are used with the Sentosa SQ HIV-1 Positive Control Kit (96/8). QIC Hiv-1 Genotyping Assay Using Ngs Technology 2 Sentosa SQ HIV-1 Positive Control Kit (8)
13 08885013956382 300316 300316 The Sentosa SQ Sequencing Kit is used to perform up to 200 base-read sequencing The Sentosa SQ Sequencing Kit is used to perform up to 200 base-read sequencing of enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonally amplified DNA. The Sentosa SQ Sequencing Kit is comprised of three components; Sentosa SQ Sequencing Supplies, Sentosa SQ Sequencing Solutions and Sentosa SQ Sequencing Reagents. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa SQ Sequencing Solutions (8)
14 08885013950076 400120 400120 ST401e is used for enrichment and forms part of SQ301 Platform. PFF High Throughput Dna Sequence Analyzer 2 Sentosa ST401e
15 08885013956535 300735 300735 The Sentosa SX IA Template Prep Kit is intended for isothermal template preparat The Sentosa SX IA Template Prep Kit is intended for isothermal template preparation after library preparation is complete. it is used to prepare enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonally amplified DNA for up to 200 base-read sequencing of a library. The Sentosa SX IA Template Prep Kit is comprised of three components; the Sentosa SX IA Reactions Kit, the Sentosa SX IA Reagents Kit and the Sentosa SX IA Solutions Kit. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa SX IA Solution Kit (8)
16 08885013956528 300734 300734 The Sentosa SX IA Template Prep Kit is intended for isothermal template preparat The Sentosa SX IA Template Prep Kit is intended for isothermal template preparation after library preparation is complete. it is used to prepare enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonally amplified DNA for up to 200 base-read sequencing of a library. The Sentosa SX IA Template Prep Kit is comprised of three components; the Sentosa SX IA Reactions Kit, the Sentosa SX IA Reagents Kit and the Sentosa SX IA Solutions Kit. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa SX IA Reagents Kit (8)
17 08885013956344 300322 300322 The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion S The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonal amplified DNA for up to 200 base-read sequencing of a library.Sentosa ST Template Kit is comprised of four components; Sentosa ST Template Supplies, Sentosa ST Template Solutions, Sentosa ST Template Reagents and Sentosa ST Template Beads. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa ST Template Beads (8)
18 08885013956399 300300 300300 The Sentosa SQ 318 Chip Kit is used to perform up to 200 base-read sequencing of The Sentosa SQ 318 Chip Kit is used to perform up to 200 base-read sequencing of enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonally amplified DNA. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa SQ 318 Chip Kit (8)
19 08885013953664 300216 300216 Sentosa SA201 HSV-1/2 PCR Test is a real-time PCR based in vitro diagnostic test Sentosa SA201 HSV-1/2 PCR Test is a real-time PCR based in vitro diagnostic test to detect and differentiate HSV1 and HSV2 virus DNA qualitatively. OQO Herpes Simplex Virus Nucleic Acid Amplification Assay 2 Sentosa SA201 HSV-1/2 PCR Test
20 08885013950045 7468 400103 The Sentosa® SQ301 Platform is an in vitro diagnostic system composed of a seque The Sentosa® SQ301 Platform is an in vitro diagnostic system composed of a sequencing instrument that measures the hydrogen ions that are generated during the incorporation of nucleotides in the DNA sequencing reaction and the ancillary instrumentation necessary for sample processing. This platform is used in conjunction with instrument-specific library preparation kits, template kits, sequencing kits, chip kits and data analysis software. The Sentosa® SQ301 Platform is intended for targeted sequencing of various biological samples. The Sentosa® SQ301 Platform is not intended for whole genome or de novo sequencing. PFF High Throughput Dna Sequence Analyzer 2 Sentosa SQ301 Sequencer
21 08885013958188 300677 300677 The ViroKey™ SX Virus Total Nucleic Acid Kit is used for magnetic beads-based nu The ViroKey™ SX Virus Total Nucleic Acid Kit is used for magnetic beads-based nucleic acid extraction from SARS-CoV-2 in nasopharyngeal and oropharyngeal swab samples in conjunction with the ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 on the Sentosa® SX101 instrument. JJH Clinical Sample Concentrator 1 ViroKey™ SX Virus Total Nucleic Acid Kit
22 08885013956511 300733 300733 The Sentosa SX IA Template Prep Kit is intended for isothermal template preparat The Sentosa SX IA Template Prep Kit is intended for isothermal template preparation after library preparation is complete. it is used to prepare enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonally amplified DNA for up to 200 base-read sequencing of a library. The Sentosa SX IA Template Prep Kit is comprised of three components; the Sentosa SX IA Reactions Kit, the Sentosa SX IA Reagents Kit and the Sentosa SX IA Solutions Kit. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa SX IA Reactions Kit (4)
23 08885013956337 300325 300325 The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion S The Sentosa ST Template Kit is used to prepare enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonal amplified DNA for up to 200 base-read sequencing of a library.Sentosa ST Template Kit is comprised of four components; Sentosa ST Template Supplies, Sentosa ST Template Solutions, Sentosa ST Template Reagents and Sentosa ST Template Beads. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa ST Template Solutions (8)
24 08885013950069 400124 400124 Sentosa ST401i is used for emulsion PCR and forms part of SQ301 Platform. PFF High Throughput Dna Sequence Analyzer 2 Sentosa ST401i
25 08885013958195 301088 301088 The ViroKey® HT Virus Total Nucleic Acid Kit (4x96) is used for magnetic beads-b The ViroKey® HT Virus Total Nucleic Acid Kit (4x96) is used for magnetic beads-based nucleic acid extraction from virus in biological specimens. ViroKey® HT Virus Total Nucleic Acid Kit (4x96)
26 08885013956368 300306 300306 The Sentosa SQ Sequencing Kit is used to perform up to 200 base-read sequencing The Sentosa SQ Sequencing Kit is used to perform up to 200 base-read sequencing of enriched, template-positive Ion Sphere™ Particles (ISPs) containing clonally amplified DNA. The Sentosa SQ Sequencing Kit is comprised of three components; Sentosa SQ Sequencing Supplies, Sentosa SQ Sequencing Solutions and Sentosa SQ Sequencing Reagents. PFT Reagents For Molecular Diagnostic Test Systems 1 Sentosa SQ Sequencing Supplies (8)
Other products with the same Product Code "QIC"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 08885013956597 300800 300800 The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-base The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) test intended for use in detecting HIV-1 genomicmutations (in the protease, reverse transcriptase and integrase regions of the pol gene), as an aid in monitoring and treating HIV-1 infection. This test is used in adjunct to the therapeutic management of patients diagnosed with HIV-1 Group M infection, with viral loads of at least 1,000 RNA copies per mL in EDTA plasma specimens.The Sentosa SQ HIV-1 Genotyping Assay consists of Sentosa SQ HIV-1 Genotyping Reagents and Sentosa SQ Virus Testing Solutions. They are used with the Sentosa SQ HIV-1 Positive Control Kit (96/8). Sentosa SQ HIV-1 Positive Control Kit (8) VELA OPERATIONS SINGAPORE PTE. LTD.
2 08885013956566 300729 300729 The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-base The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) test intended for use in detecting HIV-1 genomicmutations (in the protease, reverse transcriptase and integrase regions of the pol gene), as an aid in monitoring and treating HIV-1 infection. This test is used in adjunct to the therapeutic management of patients diagnosed with HIV-1 Group M infection, with viral loads of at least 1,000 RNA copies per mL in EDTA plasma specimens.The Sentosa SQ HIV-1 Genotyping Assay consists of Sentosa SQ HIV-1 Genotyping Reagents and Sentosa SQ Virus Testing Solutions. They are used with the Sentosa SQ HIV-1 Positive Control Kit (96/8). Sentosa SQ HIV-1 Positive Control Kit (96) VELA OPERATIONS SINGAPORE PTE. LTD.
3 08885013956559 300732 300732 The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-base The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) test intended for use in detecting HIV-1 genomicmutations (in the protease, reverse transcriptase and integrase regions of the pol gene), as an aid in monitoring and treating HIV-1 infection. This test is used in adjunct to the therapeutic management of patients diagnosed with HIV-1 Group M infection, with viral loads of at least 1,000 RNA copies per mL in EDTA plasma specimens.The Sentosa SQ HIV-1 Genotyping Assay consists of Sentosa SQ HIV-1 Genotyping Reagents and Sentosa SQ Virus Testing Solutions. They are used with the Sentosa SQ HIV-1 Positive Control Kit (96/8). Sentosa SQ Virus Testing Solutions (4x24) VELA OPERATIONS SINGAPORE PTE. LTD.
4 08885013956542 300731 300731 The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-base The Sentosa SQ HIV-1 Genotyping Assay is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) test intended for use in detecting HIV-1 genomicmutations (in the protease, reverse transcriptase and integrase regions of the pol gene), as an aid in monitoring and treating HIV-1 infection. This test is used in adjunct to the therapeutic management of patients diagnosed with HIV-1 Group M infection, with viral loads of at least 1,000 RNA copies per mL in EDTA plasma specimens.The Sentosa SQ HIV-1 Genotyping Assay consists of Sentosa SQ HIV-1 Genotyping Reagents and Sentosa SQ Virus Testing Solutions. They are used with theSentosa SQ HIV-1 Positive Control Kit (96/8). Sentosa SQ HIV-1 Genotyping Reagents (4x24) VELA OPERATIONS SINGAPORE PTE. LTD.